Search - tctmd.com

Displaying 21 - 40 of 65

Sort: Relevancy | Date

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Conference News HFSA 2023

Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships

Shelley Wood

October 13, 2023

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Conference News ESC Heart Failure 2023

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Shelley Wood

May 21, 2023

News Conference News EHRA 2023

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Michael O'Riordan

April 19, 2023

News Conference News EHRA 2023

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

Michael O'Riordan

April 18, 2023

News Features

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

Todd Neale

April 10, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News THT 2023

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

Yael L. Maxwell

March 22, 2023

News Conference News ACC 2023

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

Todd Neale

March 09, 2023

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Advertisement

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Debating the Role of T-TEER in the Sickest Patients

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

CardioMEMS Beats Standard Care in First European RCT: MONITOR-HF

Novel Score Identifies HF Patients With AF Who Respond to Ablation

Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests

How Dapagliflozin Works in HFpEF: Some Clues From CAMEO-DAPA

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content